Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Follicular Lymphoma. A Combined Analysis on Behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR

BACKGROUND: Allogeneic hematopoietic stem cell transplantation (allo-HCT) remains the only potentially curative treatment option for relapsed follicular lymphoma (FL), yet questions remain on the optimal timing. We have analysed long-term outcomes and associated factors among recipients of allo-HCT...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer
Hlavní autoři: Sureda, A., Zhang, M.-J., Dreger, P., Carreras, J., Fenske, T., Finel, H., Schouten, H., Montoto, S., Robinson, S., Smith, S. M., Boumedil, A., Hamadani, M., Pasquini, M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5946312/
https://ncbi.nlm.nih.gov/pubmed/29424927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31264
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky